Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII
Diabetes Care - United States
doi 10.2337/diacare.28.3.533
Full Text
Open PDFAbstract
Available in full text
Date
February 25, 2005
Authors
Publisher
American Diabetes Association